Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Irving

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 24, 2018
The relationship between CD34+ stem cell dose and time to neutrophil recovery in autologous haematopoietic stem cell recipients-A single centre experienceKarthik Nath, Rachael Boles, Andrew McCutchan, et al.
Pathology|September 20, 2012
Isolated intracranial myeloid sarcomaGeorgina Hodges, Hock Choong Lai, Ian Irving, et al.
Asia-Pacific Journal of Clinical Oncology|February 1, 2018
FLT3-ITD positive acute myeloid leukemia: A retrospective analysis of the role of allogeneic transplant and allelic ratio in patient managementEmma Taylor, Kirk Morris, Marc Ellis, et al.
Contemporary Clinical Trials Communications|May 9, 2018
Effects of intensive induction and consolidation chemotherapy with idarubicin and high dose cytarabine on minimal residual disease levels in newly diagnosed adult precursor-B acute lymphoblastic leukemiaKenneth F Bradstock, Alec Morley, Karen Byth, et al.
Internal Medicine Journal|March 23, 2022
Activity and outcomes of autologous stem cell transplantation in the private sector in AustraliaKarthik Nath, Yvette James, Debra Taylor, et al.
American Journal of Hematology|November 20, 2004
Hemoglobin Titusville, a low oxygen affinity variant hemoglobin, in a family of Northern European backgroundHong-Yuan Luo, Ian Irving, John Prior, et al.
Leukemia & Lymphoma|February 18, 2014
Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocolJay Hocking, Anthony P Schwarer, Robin Gasiorowski, et al.
Internal Medicine Journal|October 20, 2021
A comprehensive study of the epidemiology of haematological malignancies in North QueenslandKarthik Nath, Rachael Boles, Theophilus I Emeto, et al.
Leukemia Research|March 2, 2018
Efficacy and safety of nilotinib 300 mg twice daily in patients with chronic myeloid leukemia in chronic phase who are intolerant to prior tyrosine kinase inhibitors: Results from the Phase IIIb ENESTswift studyDevendra Hiwase, Peter Tan, James D'Rozario, et al.
Leukemia & Lymphoma|May 22, 2014
An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trialJason D Lickliter, Kerry Taylor, Jeff Szer, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 24, 2018
The relationship between CD34+ stem cell dose and time to neutrophil recovery in autologous haematopoietic stem cell recipients-A single centre experienceKarthik Nath, Rachael Boles, Andrew McCutchan, et al.
Pathology|September 20, 2012
Isolated intracranial myeloid sarcomaGeorgina Hodges, Hock Choong Lai, Ian Irving, et al.
Asia-Pacific Journal of Clinical Oncology|February 1, 2018
FLT3-ITD positive acute myeloid leukemia: A retrospective analysis of the role of allogeneic transplant and allelic ratio in patient managementEmma Taylor, Kirk Morris, Marc Ellis, et al.
Contemporary Clinical Trials Communications|May 9, 2018
Effects of intensive induction and consolidation chemotherapy with idarubicin and high dose cytarabine on minimal residual disease levels in newly diagnosed adult precursor-B acute lymphoblastic leukemiaKenneth F Bradstock, Alec Morley, Karen Byth, et al.
Internal Medicine Journal|March 23, 2022
Activity and outcomes of autologous stem cell transplantation in the private sector in AustraliaKarthik Nath, Yvette James, Debra Taylor, et al.
American Journal of Hematology|November 20, 2004
Hemoglobin Titusville, a low oxygen affinity variant hemoglobin, in a family of Northern European backgroundHong-Yuan Luo, Ian Irving, John Prior, et al.
Leukemia & Lymphoma|February 18, 2014
Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocolJay Hocking, Anthony P Schwarer, Robin Gasiorowski, et al.
Internal Medicine Journal|October 20, 2021
A comprehensive study of the epidemiology of haematological malignancies in North QueenslandKarthik Nath, Rachael Boles, Theophilus I Emeto, et al.
Leukemia Research|March 2, 2018
Efficacy and safety of nilotinib 300 mg twice daily in patients with chronic myeloid leukemia in chronic phase who are intolerant to prior tyrosine kinase inhibitors: Results from the Phase IIIb ENESTswift studyDevendra Hiwase, Peter Tan, James D'Rozario, et al.
Leukemia & Lymphoma|May 22, 2014
An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trialJason D Lickliter, Kerry Taylor, Jeff Szer, et al.
Pageof 2